ArticleMolecular biology reports2026
Regulatory roles of miRNAs in development and progression of Hepatocellular carcinoma.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatocellular carcinoma is one of the major cancers worldwide. It is most commonly caused by different factors, such as HBV, HCV infection, and alcohol consumption are most common. HCV infection causes CHC, fibrosis, and cirrhosis, which lead to HCC development. It is proven that miRNAs play an important role in the development of different types of cancer, including HCC.
methodsIn this study, we performed data mining and bioinformatics analysis to investigate the roles of miR-1297, miR-2682-5p, miR-3186-5p, and miR-4753 in various types of malignancies, with a specific focus on HCC. Moreover, their expression levels, along with biomarkers (AFP and SOX4), were checked in four study groups (G1 = healthy controls, G2 = HCV patients, G3 = HCV-induced HCC patients, G4 = HCC patients) by RT-PCR.
resultsExpression analysis revealed that miR-1297, miR-2682-5p, miR-3186-5p, and miR-4753 were significantly downregulated, whereas AFP and SOX4 were significantly upregulated in G3 group compared with G1 group. The miR-2682-5p (p = 0.0412) and miR-4753 (p = 0.0383) showed a significant negative correlation with AFP. ROC analysis revealed that miR-1297, miR-2682-5p, miR-3186-5p, and miR-4753 have significant diagnostic potential for HCC.
conclusionThe findings indicate that miR-1297, miR-2682-5p, miR-3186-5p, and miR-4753 may serve as promising biomarkers for HCC.
Indexed as
Identifiers
42496744What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.